articleThe Lancet NeurologyJan 22, 2025Closed access

Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial

Population Health Research Institute · University of British Columbia · +19 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

47
total citations
FWCI
58.22
Percentile
100%
References
40
Citations per year

Authors

23

Topics & keywords

Keywords
  • Atrial fibrillation
  • Medicine
  • Aspirin
  • Stroke (engine)
  • Apixaban
  • Subclinical infection
  • Subgroup analysis
  • Cardiology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding